Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

418 results

How to solve tricky coronary complications

16 May 2024 – From EuroPCR 2024

From balloon rupture during double-kissing crush stenting to a successful bailout for delayed coronary obstruction post-TAVI, and an unforeseen complication after chimney stenting in a high-risk patient, the session covers it all. Learn about the nuclear mushroom phenomenon during PCI in a calcified LAD, strategies for...

How to solve tricky coronary complications

Stent loss and coronary perforation: how to deal with

16 May 2024 – From EuroPCR 2024

This session explores the management of challenging complications during percutaneous coronary interventions, such as stent loss and coronary perforation. The presenters share case studies that demonstrate various techniques and strategies used to address these complications, including the use of CTO wires for distal wire perforation, managing...

Stent loss and coronary perforation: how to deal with

Mastering the future of PCI with drug-coated balloons

16 May 2024 – From EuroPCR 2024

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...

Mastering the future of PCI with drug-coated balloons

Multivessel disease PCI guided by physiology and IVUS - LIVE case

16 May 2024 – From EuroPCR 2024

A 78-year-old woman with hypertension, dyslipidemia, and obesity, presented with angina CCS2 and preserved LV function. The coronary angiogram showed stenosis in the RCA (proximal and mid), CX, and calcified proximal and mid LAD involving D1 and D2.
The operators performed PCI on the RCA (1 stent)...

Multivessel Disease: A LIVE Educational Case from Spain

Comparative insights into QFR, FFR, and angiography

16 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...

Comparative insights into QFR, FFR, and angiography

Tackling challenging scenarios of left main PCI

16 May 2024 – From EuroPCR 2024

This session, with the collaboration of the South African Society of Cardiovascular Intervention (SASCI), Bangladesh Society of Cardiovascular Intervention and Indonesian Society of Interventional Cardiology, focuses on overcoming the most challenging issues in complex left main bifurcation stenosis PCI. It includes case discussions on techniques to...

Tackling challenging scenarios of left main PCI

Acute coronary syndrome caused by coronary aneurysms

16 May 2024 – From EuroPCR 2024

This session will explore various cases of acute coronary syndromes caused by coronary artery aneurysms. Participants will learn about the diagnosis, management, and treatment strategies for these rare and complex cases, including the use of imaging and interventional techniques to address the underlying pathology.

Acute coronary syndrome caused by coronary aneurysms

PCI to treat the bystander disease in STEMI patients: who, when and how?

16 May 2024 – From EuroPCR 2024

Watch this case-based session on PCI for STEMI to see how the guidelines are influenced by the COMPLETE trial. Learn why and how physiology can guide intermediate lesions, the importance of intracoronary imaging guidance, the value of complete revascularization in STEMI patients, the optimal method for...

PCI to treat the bystander disease in STEMI patients: who, when and how?

Make your life easier with imaging during primary PCI for acute coronary syndrome

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions highlighting the use of imaging modalities, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), during primary percutaneous coronary interventions (PCI) for acute coronary syndrome. Experts will present and discuss challenging cases, demonstrating how the integration...

Make your life easier with imaging during primary PCI for acute coronary syndrome

Hemodynamic support during CTO PCI: to use it or not?

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions focused on the use of hemodynamic support devices during percutaneous coronary interventions (PCI) for chronic total occlusions (CTO). Experts will present and discuss challenging cases where the use of devices like the Impella pump or pulsatile left...

Hemodynamic support during CTO PCI: to use it or not?